Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: J Neurochem. 2009 May 29;110(3):990–1004. doi: 10.1111/j.1471-4159.2009.06194.x

Fig. 7. Reversal of the NCX during glutamate treatment of cortical neurons.

Fig. 7

(a-c) Cortical neurons were wide-field fluorescence imaged to quantify the glutamate-triggered rise of [Ca2+]c with Fura-4F (a) and in separate experiments the rise of [Na+]c (b) and the depolarization of the ΔΨP (c), using SBFI and PMPI, respectively. Glutamate (100 μM) plus glycine (10 μM) were applied in the absence of Mg2+ with a perfusion system (Glu), and then were washed out with Mg2+-containing (1 mM) experimental medium. (d) The thermodynamic driving force of the NCX was calculated from the data shown in (a-c). The [Ca2+]e and [Na+]e were 1.3 mM and 136 mM respectively. A negative ΔG was defined as the forward mode of exchange; i.e. pumping Ca2+ out from the cell, while positive ΔG indicates reversal of the NCX. (e) Effect of the reverse-mode NCX inhibitor KB-R7943 (KBR; 10 μM) on the glutamate-triggered [Ca2+]c plateau. Drug application was performed with a perfusion system with nifedipine (1 μM) continuously present in all perfusion lines. Data are mean ± SE of neurons pooled from 6 experiments per condition performed in 3 cell culture preparations (n=385, 202, 202, and 169 for (a), (b), (c), and (d), respectively). The SE in (d) was propagated from (a-c).